Colleen Annesley, MD
Seattle Children's Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Colleen Annesley, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:45 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT07148050 · Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T CellsSeattle Children's Hospital · recruiting · Solid Tumor (Excluding CNS), Liver Cell Carcinoma, Malignant Rhabdoid Tumor · study director
- Ph1NCT06465147 · REACT-01: Reversing Autoimmunity Through Cell TherapySeattle Children's Hospital · recruiting · Systemic Lupus Erythematosus · study director
- Ph1NCT03684889 · CD19-specific CAR T Cells With a Fully Human Binding Domain for CD19+ Leukemia or LymphomaSeattle Children's Hospital · active not recruiting · Leukemia, Lymphoma · study chair
- Ph1NCT03330691 · A Feasibility and Safety Study of Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy for CD19+CD22+ LeukemiaSeattle Children's Hospital · active not recruiting · Leukemia, Lymphoma · study chair
- Ph1NCT03186118 · Pilot Study of T-APCs Following CAR T Cell Immunotherapy for CD19+ LeukemiaSeattle Children's Hospital · active not recruiting · CD 19+ Acute Leukemia · study chair
- Ph1/Ph2NCT02028455 · A Pediatric and Young Adult Trial of Genetically Modified T Cells Directed Against CD19 for Relapsed/Refractory CD19+ LeukemiaSeattle Children's Hospital · active not recruiting · CD19+ Acute Leukemia · study chair
- Ph1NCT01683279 · A Pediatric Trial of Genetically Modified Autologous T Cells Directed Against CD19 for Relapsed CD19+ Acute Lymphoblastic LeukemiaSeattle Children's Hospital · active not recruiting · B Cell Leukemia · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:45 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in atypical teratoid rhabdoid tumour (at/rt).